LabGenomics Co., Ltd. (KOSDAQ: 084650)
South Korea
· Delayed Price · Currency is KRW 2,910.00
-60.00 (-2.02%)
Jan 21, 2025, 3:00 PM KST
LabGenomics Revenue
LabGenomics had revenue of 21.65B KRW in the quarter ending September 30, 2024, with 2.25% growth. This brings the company's revenue in the last twelve months to 85.82B, up 22.86% year-over-year. In the year 2023, LabGenomics had annual revenue of 73.13B, down -49.49%.
Revenue (ttm)
85.82B
Revenue Growth
+22.86%
P/S Ratio
2.52
Revenue / Employee
504.80M
Employees
170
Market Cap
216.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 73.13B | -71.65B | -49.49% |
| Dec 31, 2022 | 144.77B | -57.63B | -28.47% |
| Dec 31, 2021 | 202.41B | 82.93B | 69.41% |
| Dec 31, 2020 | 119.48B | 86.30B | 260.14% |
| Dec 31, 2019 | 33.18B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 292.86T |
| SK hynix | 57.73T |
| LG Energy Solution | 27.17T |
| Samsung Biologics Co.,Ltd. | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Kia Corporation | 104.63T |
| Celltrion | 2,876.25B |
| KB Financial Group | 14.11T |